Publication date: Available online 29 October 2026 Source: The Lancet Microbe Author(s): Joel V Chua, Angie Price, Salma Sharaf, Sigrid Camacho Ortega, Paula J Bernal, Lauryn Butler, Abra Rachida Koudjra, Sudhaunshu Joshi, Céline S C Hardy, Jeffrey R Currier, Adam T Waickman, Cristiana Cairo, Heather Friberg, Robert Edelman, Kirsten E Lyke
Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study. // The Lancet Microbe. – URL: https://www.sciencedirect.com/science/article/pii/S2666524726001977?dgcid=rss_sd_all
Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study. The Lancet Microbe. https://www.sciencedirect.com/science/article/pii/S2666524726001977?dgcid=rss_sd_all
“Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study.” The Lancet Microbe.
@article{article68923,
title = {Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study},
journal = {The Lancet Microbe},
url = {https://www.sciencedirect.com/science/article/pii/S2666524726001977?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Clinical Epidemiology and Global Health, Volume 42 Author(s): Dennis Kithinji, Fausto Ciccacci, Benjamin Welu, Harrison Ndoi, Claudia Mosconi, Carolina De Santo, Mariachiara Carestia,...
Publication date: November–December 2026 Source: Clinical Epidemiology and Global Health, Volume 42 Author(s): Alex S. Borromeo, Allan M. Manaloto, Rhealeen V. Vicedo, Jessica C. Villano, Maribel F. Valencia, Walton Wider